The principal translocated sites in DLBCL are a rearrangement of BCL6 (30% of cases) and t(14;18)(q32;q21) with BCL2 rearrangement to the IGH gene locus (20–30% of cases) [140,141]. The gene discussed is BCL2; the disease is diffuse large B-cell lymphoma.